how expensive are glp 1 drugs New Drugs for Weight Loss What Plan Sponsors Need to Know How Employers Can Manage GLP-1

Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88

These cost-saving results have implications for patients, physicians, insurers, and governments

Learn what the ads don't tell you, and how lifestyle medicine offers a more lasting path.

Glucagon-like peptide 1 (GLP1) receptor agonists reduce the rate of major adverse cardiovascular events in people with type 2 diabetes mellitus

The majority of T2D management is in primary care, where clinicians (medical, nursing and pharmacist staff) play an important role in addressing patient needs and achieving treatment goals

Those with obesity might have other serious chronic health conditions, including diabetes and high blood pressure, which are leading risk factors for heart disease and stroke